Literature DB >> 19196064

Differentiating primary from secondary hyperparathyroidism in stone patients: the "thiazide challenge".

Brian H Eisner1, Jennifer Ahn, Marshall L Stoller.   

Abstract

Differentiating between resorptive hypercalciuria (i.e., primary hyperparathyroidism) and renal leak hypercalciuria (i.e., secondary hyperparathyroidism) in the patient with stones and with hypercalciuria and elevated serum parathyroid hormone is important. Primary hyperparathyroidism necessitates endocrine surgery, while secondary hyperparathyroidism is managed with long-term thiazide diuretics. We present a reliable method for distinguishing between these two conditions: The "thiazide challenge."

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196064     DOI: 10.1089/end.2008.0567

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  6 in total

1.  Medical evaluation and management of urolithiasis.

Authors:  Michelle Jo Semins; Brian R Matlaga
Journal:  Ther Adv Urol       Date:  2010-02

2.  Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades.

Authors:  Marcio L Griebeler; Ann E Kearns; Euijung Ryu; Prabin Thapa; Matthew A Hathcock; L Joseph Melton; Robert A Wermers
Journal:  J Clin Endocrinol Metab       Date:  2016-01-11       Impact factor: 5.958

3.  Effect of thiazides on bone mineral density in children with idiopathic hypercalciuria.

Authors:  Víctor García-Nieto; Margarita Monge-Zamorano; Montserrat González-García; María Isabel Luis-Yanes
Journal:  Pediatr Nephrol       Date:  2011-08-28       Impact factor: 3.714

4.  Nephrolithiasis: Endocrine evaluation.

Authors:  Salam Ranabir; Manash P Baruah; K Reetu Devi
Journal:  Indian J Endocrinol Metab       Date:  2012-03

5.  European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders.

Authors:  Jens Bollerslev; Lars Rejnmark; Alexandra Zahn; Ansgar Heck; N M Appelman-Dijkstra; Luis Cardoso; Fadil M Hannan; Filomena Cetani; Tanja Sikjær; Anna Maria Formenti; Sigridur Björnsdottir; Camilla Schalin-Jantti; Zhanna Belaya; Fraser Wilson Gibb; Bruno Lapauw; Karin Amrein; Corinna Wicke; Corinna Grasemann; Michael Krebs; Eeva M Ryhänen; Ozer Makay; Salvatore Minisola; Sebastien Gaujoux; Jean-Philippe Bertocchio; Zaki K Hassan-Smith; Agnès Linglart; Elizabeth M Winter; Martina Kollmann; Hans-Georg Zmierczak; Elena Tsourdi; Stefan Pilz; Heide Siggelkow; Neil J Gittoes; Claudio Marcocci; Peter Kamenicky
Journal:  Eur J Endocrinol       Date:  2022-01-13       Impact factor: 6.664

6.  Hypercalciuria in Postmenopausal Women With Reduced Bone Mineral Density Is Associated With Different Mineral Metabolic Profiles: Effects of Treatment With Thiazides and Anti-resorptives.

Authors:  Federico Nicoli; Giorgia Dito; Gregorio Guabello; Matteo Longhi; Sabrina Corbetta
Journal:  Front Med (Lausanne)       Date:  2021-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.